← Back to headlines
Innoscripta Shares Drop 9% Following Q2 2026 Financial Update
Biotech company Innoscripta saw its stock decline nearly 9% after releasing its second-quarter 2026 results and hosting an investor call, reflecting market sentiment on its latest operational guidance.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
